newsfilter
← Latest News
GlobeNewswire·

INVO Fertility Aligns Executive Leadership Structure to Support Growth Strategy

  • INVO Fertility, Inc. announced executive leadership changes to align with its growth strategy focused on acquiring & establishing fertility clinics.
  • Terah Krigsvold, previously controller since December 2020, was appointed as the new chief financial officer.
  • Andrea Goren, previously chief financial officer since July 2021, was appointed as chief business officer & CEO of INVO Centers LLC.
  • CEO Steve Shum stated the realignment strengthens the company's ability to execute its growth plan & reach profitability.
  • Goren will leverage his experience with approximately $1 billion in financing & acquisition transactions to lead negotiations, legal diligence, & new clinic launches.
  • Goren will continue managing the legal function while supporting investor & shareholder activities.
  • INVO Fertility operates two INVO Centers & one IVF clinic in the US, while also distributing its proprietary INVOcell device to third-party clinics.
  • The INVOcell device enables intravaginal culture (IVC), allowing fertilization & early embryo development within the woman's body.
  • The release included a standard safe harbor statement regarding forward-looking statements & associated risks.